n-
Non vérifié

n-Lorem Foundation

Ce que nous écrivons

Associations/ProfessionnelsBiotechnologieIndustrie pharmaceutiqueSantéScience
19/03/2026
Science
Biotechnologie
Industrie pharmaceutique
Santé
Associations/Professionnels
Volontariat/Solidarité/Bénévolat
Industrie
n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines
1.00
02/10/2025
Science
Biotechnologie
Associations/Professionnels
Santé
Industrie pharmaceutique
Volontariat/Solidarité/Bénévolat
Événements
n-Lorem Foundation Organizes Third Annual Nano-rare Patient Colloquium, Highlighting Scientific and Clinical Advancements Achieved Since Organization’s Founding
1.00
19/08/2025
Science
Industrie pharmaceutique
Santé
Biotechnologie
Associations/Professionnels
Volontariat/Solidarité/Bénévolat
n-Lorem Foundation Publishes Study Showing Targeted ASO Therapy Restores GBE1 Protein in APBD Patient Cells
1.00
08/05/2025
Science
Biotechnologie
Santé
Associations/Professionnels
Santé Publique
n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients
1.00
15/04/2025
Multimédia
Industrie
Biotechnologie
Associations/Professionnels
Santé Publique
Industrie pharmaceutique
Santé
n-Lorem Foundation Celebrates Five Years of Bringing Hope and Potential Treatments to Nano-rare Patients
1.00
12/12/2024
Industrie
Science
Biotechnologie
Médecine - Divers
Associations/Professionnels
Santé Publique
Industrie pharmaceutique
Santé
n-Lorem Foundation’s Nano-rare Patient Colloquium Draws More Than 750 attendees, Reinforcing Need for Treatment Options for People with Nano-rare Illnesses
1.00
30/10/2024
Web et Réseaux Sociaux
Volontariat/Solidarité/Bénévolat
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé
Associations/Professionnels
n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End
1.00
03/10/2024
Analyse de marché
Volontariat/Solidarité/Bénévolat
Science
Biotechnologie
Industrie pharmaceutique
Santé
Associations/Professionnels
n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations
1.00
09/08/2024
Science
Industrie pharmaceutique
Associations/Professionnels
Vitrines/Shopping
Biotechnologie
Enfance
Médecine - Divers
Santé
Volontariat/Solidarité/Bénévolat
Industrie
Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine
1.00
27/07/2023
Accessoires
Vitrines/Shopping
Santé
Fitness/Bien-être
Formation professionnelle
École/Enseignement
Volontariat/Solidarité/Bénévolat
Associations/Professionnels
Administration Publique
Médecine - Divers
Science
n-Lorem Has Industrialized the Treatment of Nano-rare Patients and Formed Key Committees
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0